Efficacy of Ondansetron as a Prophylactic Anti-Hypotensive Pharmacologic Intervention Among Obese Parturients Undergoing Spinal Anesthesia for Cesarean Delivery

  • Melissa Dawn Hudson, DNP, MSNA, CRNA, APRN Gonzaga University http://orcid.org/0000-0002-4269-9521
  • Neva L Crogan, Ph.D, ARNP, GNP-BC, FNGNA, FAAN Gonzaga University
  • Edward J Bilsky, PhD University of New England

Abstract

Background and Purpose

Obesity has been identified as a risk factor for hypotension after spinal anesthesia among parturients undergoing cesarean delivery. Although researchers have demonstrated prophylactic administration of ondansetron as efficacious in attenuating maternal hypotension following spinal anesthesia, no studies have examined the efficacy of prophylactic ondansetron in the high risk population of obese parturients. The primary objective of this study was to assess the efficacy of the novel application of ondansetron as a prophylactic anti-hypotensive pharmacologic intervention among obese parturients in order to facilitate practice recommendations that aim to reduce maternal-fetal risk associated with the administration of spinal anesthesia for cesarean delivery.

Methods

Retrospective chart analyses of 46 patients with BMI > 30 were conducted between August 1, 2014 and May 10, 2015 to determine whether the intravenous administration of 4 mg ondansetron prior to the induction of spinal anesthesia reduced frequency of vasopressor administration during cesarean section.

Results

The incidence of vasopressor administration among patients who received prophylactic ondansetron was 35.7%, whereas 46.9% of patients who did not receive prophylactic ondansetron required vasopressor administration (χ2 = 0.144, df = 1, p = 0.704).

Conclusions

Obese parturients undergoing spinal anesthesia for cesarean delivery demonstrated improvements in hemodynamic stability when prophylactically treated with ondansetron.


 

Author Biographies

Melissa Dawn Hudson, DNP, MSNA, CRNA, APRN, Gonzaga University

Melissa D. Hudson, CRNA, APRN, MSNA, DNPc received her BSN from Washington State University Honors College in 2004 and her MSNA from the University of New England in 2008. She is a candidate for the degree of Doctor of Nursing Practice at Gonzaga University and a practicing nurse anesthetist at a critical access hospital in rural Washington State.

Neva L Crogan, Ph.D, ARNP, GNP-BC, FNGNA, FAAN, Gonzaga University

Neva Crogan, Ph.D., GNP-BC, ENGNA, FAAN received her BSN from the University of the State of New York in 1983, a Master’s in Nursing from Eastern Washington University in 1992 and a PhD from Washington State University in 1998. Her post-doctorate education includes a Geriatric Nurse Practitioner Certificate in 2007 from the University of Virginia. She is a Fellow of the American Academy of Nursing and was the co-recipient of the 2013 Sigma Theta Tau International Research Utilization Award. She has published more than 60 data based research articles and has presented at multiple regional, national and international conferences.

Edward J Bilsky, PhD, University of New England

Edward J. Bilsky, Ph.D., currently serves as the Vice President for Research and Scholarship at the University of New England. He received his B.S. (physics) in 1989 and M.S. (Behavioral Neuroscience) in 1991 from Rensselaer Polytechnic Institute. He earned a Ph.D. in Pharmacology and Toxicology from the University of Arizona Colleges of Medicine and Pharmacy in 1996. Dr. Bilsky is currently a tenured Professor of Pharmacology and is the Founding Director of the Center of Excellence in Neuroscience. He has served as the chair of the University of New England Faculty Assembly and is an Associate Editor for Life Sciences, a journal publishing research in the biomedical sciences. He was recently awarded the 2011 AOA Research Mentor of the Year Award.

References

1 World Health Organization (WHO). Obesity and overweight. 2012. http://www.who.int/mediacentre/factsheets/fs311/en. Accessed March 17, 2015.
¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬___________________________________________________________________________
2 Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system. 2013. http://www.cdc.gov/brfss/index.htm. Accessed March 22, 2015.
___________________________________________________________________________
3 Levi J, Segal L, St. Laurent R, et al. F as in Fat: How Obesity Threatens America’s Future. Princeton, NJ: Robert Wood Johnson Foundation; 2012.
___________________________________________________________________________
4 Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity among adults: United States, 2011-2012. NCHS data brief no. 131. 2013. http://www.cdc.gov/nchs/data/databriefs/db131.pdf. Accessed March 17, 2015.
___________________________________________________________________________
5 Centers for Disease Control and Prevention (CDC). Pregnancy complications. 2014. http://www.cdc.gov/reproductivehealth/maternalinfanthealth/pregcomplications.htm#n5. Accessed March 11, 2015.
___________________________________________________________________________
6 Chu SY, Bachman DJ, Callaghan WM, et al. Association between obesity during pregnancy and increased use of healthcare. N Engl J Med. 2008;358(14):1444–53.
___________________________________________________________________________
7 Tan C, Sia AC. Anesthesia considerations in the obese gravida. Semin Perinatal. 2011;35(6):350–5, 350.
___________________________________________________________________________
8 Nani F, Torres M. Correlation between the body mass index (BMI) of pregnant women and the development of hypotension after spinal anesthesia for cesarean section. Rev Bras Anest. 2011;61(1):21–30.
___________________________________________________________________________
9 Borgeat A, Ekatodramis G, Schenker C A. Postoperative nausea and vomiting in regional anesthesia. Anesthesiology 2003;98:530–547.
___________________________________________________________________________
10 Sahoo T, SenDasgupta C, Goswami A, et al. Reduction in spinal-induced hypotension with ondansetron in parturients undergoing caesarean section: A double-blind, randomized, placebo-controlled study. International Journal of Obstetric Anesthesia. 2012;21(1):24–8.
___________________________________________________________________________
11 Wang M, Zhuo, L, Wang Q, et al. Efficacy of prophylactic intravenous ondansetron on the prevention of hypotension during cesarean delivery: A dose-dependent study. Int J Clinic Exp Med. 2014;7(12):5210–5216.
___________________________________________________________________________
12 Liu SS, McDonald SB. Current issues in spinal anesthesia. Anesthesiology 2001;94:888–906.
___________________________________________________________________________
13 CDC. Overweight and obesity. 2014. http://www.cdc.gov/obesity/data/adult.html. Accessed March 17, 2015.
___________________________________________________________________________
14 Wang Q, Zhuo L, Shen MK, et al. Ondansetron preloading with crystalloid infusion reduces maternal hypotension during cesarean delivery. Am J Perinatol. 2014;31(10):913–22.
___________________________________________________________________________
15 Cooper GM, McClure JH. Anaesthesia. In Saving Mothers’ Lives: Reviewing maternal deaths due to make pregnancy safer. Br J Anaesth. 2008;100(1):17–22.
___________________________________________________________________________
16 Butwick A, Carvalho B, Danial C, et al. Retrospective analysis of anesthetic interventions for obese patients undergoing elective cesarean delivery. J Clin Anesth. 2010;22(7):519–26.
___________________________________________________________________________
17 Edomwonyi NP, Osaigbovo PE. Incidence of obesity in parturients scheduled for caesarean section, intra-operative complications, management and outcome. East Afr Med J. 2006;83(4):112–19.
___________________________________________________________________________
18 Horikawa Y, Fukuda H, Kawakami T, et al. The effect of obesity on spinal anesthesia for cesarean section. Masui. 2001;50(11):1205–08.
___________________________________________________________________________
19 Johnson D. Management of cesarean delivery in the morbidly obese woman. Contemporary OB/GYN. 2012;57(10):57–61. http://contemporaryobgyn.modernmedicine.com/contemporary-obgyn/news/modernmedicine/modern-medicine-feature-articles/management-cesarean-delivery.
___________________________________________________________________________
20 Rodrigues FR, Brandao MJ. Regional anesthesia for cesarean section in obese pregnant women: A retrospective study. Brazilian Journal of Anesthesiology 2001;61(1):13–20.
___________________________________________________________________________
21 Roofthooft E. Anesthesia for the morbidly obese parturient. Curr Opin Anesth. 2009;22(3):341–6.
___________________________________________________________________________
22 Vricella L, Louis J, Mercer B, et al. Anesthesia complications during scheduled cesarean delivery for morbidly obese women. Am J Obstet Gynecol. 2010;203(3):276.e1–276.e5.
___________________________________________________________________________
23 HHS (US Department of Health and Human Services). Office of Disease Prevention & Health. Healthy People 2020 topics & objectives. 2011. http://healthypeople.gov/2020.
___________________________________________________________________________
24 Campbell, I. Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Stat Med. 2007;26:3661–75.
___________________________________________________________________________
25 Cochran, W. G. The 2 test of goodness of t. Ann Math Statist. 1952;25:315–45.
___________________________________________________________________________
26 Fisher, R. A. The logic of inductive inference. J Royal Stat. 1934;98:39–54.
___________________________________________________________________________
Published
2016-09-13
How to Cite
HUDSON, DNP, MSNA, CRNA, APRN, Melissa Dawn; CROGAN, PH.D, ARNP, GNP-BC, FNGNA, FAAN, Neva L; BILSKY, PHD, Edward J. Efficacy of Ondansetron as a Prophylactic Anti-Hypotensive Pharmacologic Intervention Among Obese Parturients Undergoing Spinal Anesthesia for Cesarean Delivery. Anesthesia eJournal, [S.l.], v. 4, n. 1, sep. 2016. ISSN 2333-2611. Available at: <https://anesthesiaejournal.com/index.php/aej/article/view/46>. Date accessed: 24 feb. 2020.
Section
Articles

Keywords

Ondansetron; obesity; pregnancy; spinal anesthesia; hypotension; cesarean delivery